Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):314-22

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,481


eTOC

 

ORIGINAL ARTICLE  


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 September;61(3):314-22

DOI: 10.23736/S1824-4785.17.02758-3

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer

Ummuhan ABDULREZZAK 1 , Ahmet TUTUS 1, Ilknur ISIK 2, Yurdagul KURT 1, Mustafa KULA 1

1 Department of Nuclear Medicine, Erciyes University, School of Medicine, Kayseri, Turkey; 2 Department of Nuclear Medicine, Dumlupınar University, School of Medicine, Kütahya, Turkey


PDF  


BACKGROUND: The aim of this paper was to compare the results of postoperative I-131 remnant ablation therapy using a quantitative data in the low activity (1110 MBq) and standard dose (3700 MBq).
METHODS: The study included two groups of patients with low risk differentiated thyroid cancer (DTC): Group L (low dose group) included 54 patients who were treated with 1110 MBq I-131 and Group S (standard dose group) included 61 patients treated with 3700 MBq. The postoperative thyroid remnants were assessed with the pretreatment thyroid uptake test (PTUT) and the whole body scans (WBS) were performed in the 7th day after the ablation treatment. We obtained the average count per pixel from the standard region of interest analysis of the thyroid bed (Tavc), liver (Lavc), thigh (Thavc) and whole body (WBkc). At the sixth month after the treatment, WBS were performed to 106 patients (45 patients from Group L and 61 patients from Group S) to evaluate the success of ablation treatment.
RESULTS: A significant difference in PTUT and Tavc was not found between the two groups (P>0.05). However, Lavc, Thavc and WBkc were significantly higher in Group S compared with Group L (P<0.001). Although the percentage of ablation was higher in Group S (49 of 61 patients, 80.3% versus 34 of 45 patients, 75.6%), the statistical difference was not significant (P>0.05).
CONCLUSIONS: In low risk DTC patients, low dose radioactive iodine can ablate thyroid remnants as effectively as a higher dose with less radiation exposure to other non-target organs and the whole body.


KEY WORDS: Thyroid neoplasms - Therapeutics - Gamma cameras

top of page

Publication History

Issue published online: July 6, 2017
Article first published online: January 20, 2015
Manuscript accepted: January 14, 2015
Manuscript revised: December 16, 2014
Manuscript received: September 18, 2014

Cite this article as

Abdulrezzak U, Tutus A, Isik I, Kurt Y, Kula M. Quantitative comparison of low dose and standard dose radioiodine therapy effectiveness in patients with low risk differentiated thyroid cancer. Q J Nucl Med Mol Imaging 2017;61:314-22. DOI: 10.23736/S1824-4785.17.02758-3

Corresponding author e-mail

ummuhan@erciyes.edu.tr